S'abonner

Asthmatic bronchial smooth muscle migration towards rhinovirus-infected epithelium through a CXCR3 isoform-dependant pathway - 09/06/21

Doi : 10.1016/j.rmr.2021.02.007 
A. Celle 1, 2, , P. Esteves 1, 2, M. Thumerel 1, 2, 3, P.O. Girodet 1, 2, 3, P. Berger 1, 2, 3, T. Trian 1, 2
1 Univ-Bordeaux, Centre de Recherche Cardio-thoracique de Bordeaux, U1045 
2 Inserm, Centre de Recherche Cardio-thoracique de Bordeaux, U1045, CIC 1401 
3 CHU de Bordeaux, Service d’Exploration Fonctionnelle Respiratoire, Service de Chirurgie Thoracique, CIC 1401 

Corresponding author.

Bienvenue sur EM-consulte, la référence des professionnels de santé.
Article gratuit.

Connectez-vous pour en bénéficier!

Résumé

Introduction

Asthma is the most common chronic respiratory disease. In severe patients, one of the main feature of the physiopathology is the increased bronchial smooth muscle (BSM) mass, which is related to frequency and severity of asthma exacerbations. Exacerbations are mainly triggered by rhinovirus infection of the epithelium. In addition, histology analysis has shown that distance between BSM cells and epithelium decrease proportionally to the severity of the disease. We thus hypothesis that rhinovirus infection of the epithelium increase the migration of asthmatic BSM cells.

Methods

Primary BSM cells from control and asthmatic patients were obtained from bronchial biopsies. Epithelial cells were cultivated in an air-liquid Interface. After complete differentiation, epithelium were exposed to RVA-16 (MOI 0,1) and epithelium supernatant were collected 24h post infection. BSM migration was assessed in response to epithelium supernatant in a chemotaxis assay for 24h using live microscopy. Transcriptomics and ELISA were used to analysed chemokine content within the epithelial supernatant. Immunohistochemistry and flow cytometry were used to quantify CXCR3 isoforms distribution (i.e CXCR3 A and B). Finally, western blot, cAMP assay and Ca2+ fluorometric probes were used to assess CXCR3 activation pathway.

Results

BSM cells from asthmatics migrates towards RV-infected epithelium whereas such a chemotactic effect was not observed in control BSM cells. Analysis of epithelium supernatant show that CXCL9 and CXCL10 were both induced by RVA-16. Interestingly, blocking of CXCR3 receptor, which is activated, by both CXCL9 and 10 abolished asthmatic BSM migration. They are two main isoforms of CXCR3 (A and B) which are described as activator and inhibitor of cell migration reciprocally. Interestingly, CXCR3-B expression and activation pathway through PKC and cAMP are increased in control BSM cells whereas CXCR3-A signalling pathway through calcium and Raf-1 activation are increase in asthmatic BSM cells.

Conclusion

Asthmatic BSM cells specifically migrate toward RV-infected epithelium through the activation of CXCR3-A. This new mechanism could be a new therapeutic target against BSM remodelling in asthma.

Le texte complet de cet article est disponible en PDF.

Keyword : Asthma


Plan


© 2021  Publié par Elsevier Masson SAS.
Imprimer
Export

    Export citations

  • Fichier

  • Contenu

Vol 38 - N° 6

P. 572 - juin 2021 Retour au numéro
Article précédent Article précédent
  • Identification d’un métabolite immunorégulateur de l’hôte qui protège contre la pneumonie grippale
  • A. Cezard, A. Guillon, M. Si-Tahar
| Article suivant Article suivant
  • Rôle de la Transglutaminase 2 dans les modifications du mucus dans l’asthme
  • M. Le Brun, C. Sallon, S. Bedja, F. Hamidi, P. Mordant, M. Pretolani, C. Taillé, S. Létuvé